Alternative-drug finder

If this one is blocked, consider these.

When a drug's supply route is at risk, the most useful answer is often a different approved drug entirely. We traverse the graph — from the at-risk drug, across the condition it treats and how it works — to other FDA-approved drugs whose routes aren't blocked.

At-risk drug Amoxicillin Side-chain (D-HPG) blocked; KSMs single-country.

treats →

Shared condition / mechanism CAP β-lactam cell-wall inhibition

← treats

Approved alternatives 5 candidates ranked by their own supply risk, lowest first.

Match by

Sort

Amoxicillin itself has a computationally proposed US-sourceable route (plausibility 0.72) and a compounding-pharmacy path. An alternative drug is one option among several — always read each candidate's own chokepoints before relying on it.